Following months of consultations with industry experts and critics of artificial intelligence (AI), lawmakers in the United States have introduced a bipartisan bill aimed at enabling the Biden administration to implement export controls on the most advanced AI models developed within the country. Recognizing the significance of AI investments in maintaining America’s competitiveness against foreign adversaries and enhancing the quality of life for its citizens, the bipartisan working group highlighted the potential of AI in advancing medical treatments for conditions such as cancer and chronic diseases. Stay updated with the latest technology news by accessing NEWSLINKER.
